Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma-Reference-Cited by-同舟云学术

Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma

Published:1996-08 Issue:4 Volume:52 Page:275-280
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Avilés Agustin,Guzmán Renaldo,Delgado Serafin,Nambo M. Jesús,García Edna L.,Díaz-Maqueo José C.

Publisher

Wiley

Subject

Hematology

Reference28 articles.

1. Management of Head Injury

2. Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variables

3. The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma.

4. Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-hodgkin's lymphoma

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STATEMENT OF RETRACTION;Leukemia & Lymphoma;2013-06-19

2. Comparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low–intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocol;Leukemia & Lymphoma;2010-08-31

3. Interferon alfa 2b as maintenance therapy in poor risk diffuse large B-cell lymphoma in complete remission after intensive CHOP-BLEO regimens;European Journal of Haematology;2008-07-18

4. Retracted: Adjuvant Radiotherapy in Stage IV Diffuse Large Cell Lymphoma Improve Outcome;Leukemia & Lymphoma;2004-07

5. Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy;Annals of Hematology;2002-07-01